In this episode of the Life Science Success Podcast, Dean Petkanas, co-founder of Kannalife Sciences, is interviewed at the Bio International Convention in San Diego. Dean shares his journey from investment banking in the 80s to founding Kannalife Sciences in 2009. He discusses the company's focus on developing cannabinoid-based drugs, specifically targeting chemotherapy-induced peripheral neuropathy. The conversation covers the challenges and opportunities in cannabinoid drug development, the importance of targeting specific types of pain, and the current state and future prospects of Kannalife Sciences. Dean also highlights the significance of partnering and collaboration in advancing novel therapeutics.
00:00 Welcome to the Life Science Success Podcast
00:20 Dean's Journey into Life Sciences
01:04 The Evolution of Kannalife Sciences
02:18 Challenges and Opportunities in Cannabinoid-Based Drugs
03:06 Understanding Pain and Neuropathy
06:08 Investment Insights and Market Trends
07:40 Kannalife Sciences's Current Focus and Future Prospects
10:02 The Importance of Partnering at Bio
11:02 Closing Remarks and Future Meetings
Please check out our Life Science Success Resources. You will find tools that will support growing companies and books for authors I have interviewed.